Abe Y - Search Results

1

[Induction treatment with bortezomib-cyclophosphamide-dexamethasone (CyBorD) for newly diagnosed transplant-eligible patients with multiple myeloma].

Tsukada N, Ikeda M, Shingaki S, Miyazaki K, Meshitsuka S, Yoshiki Y, Abe Y, Suzuki K. Tsukada N, et al. Among authors: abe y. Rinsho Ketsueki. 2015 Aug;56(8):1069-75. doi: 10.11406/rinketsu.56.1069. Rinsho Ketsueki. 2015. PMID: 26345569 Japanese.

2

Follicular lymphoma with marked infiltration of eosinophils.

Shiraishi J, Nakagawa Y, Kurata M, Yamamoto K, Abe Y, Toyoda Y, Suzuki K, Kitagawa M, Takemura T. Shiraishi J, et al. Among authors: abe y. Pathol Int. 2008 Nov;58(11):701-5. doi: 10.1111/j.1440-1827.2008.02296.x. Pathol Int. 2008. PMID: 18844935

3

Clinical and immunological evaluation of zoledronate-activated Vgamma9gammadelta T-cell-based immunotherapy for patients with multiple myeloma.

Abe Y, Muto M, Nieda M, Nakagawa Y, Nicol A, Kaneko T, Goto S, Yokokawa K, Suzuki K. Abe Y, et al. Exp Hematol. 2009 Aug;37(8):956-68. doi: 10.1016/j.exphem.2009.04.008. Epub 2009 May 4. Exp Hematol. 2009. PMID: 19409955 Free article. Clinical Trial.

4

[Case report: a patient with a six-month history of fever of unknown origin, followed by various manifestations of the central nervous system, finally diagnosed as having intravascular lymphoma by random skin biopsy].

Hagiwara K, Abe Y, Sato T, Inokuma S, Akiyama O, Suzuki K, Sato H, Imakado S, Takemura T. Hagiwara K, et al. Among authors: abe y. Nihon Naika Gakkai Zasshi. 2011 Jul 10;100(7):1956-8. doi: 10.2169/naika.100.1956. Nihon Naika Gakkai Zasshi. 2011. PMID: 21863769 Japanese. No abstract available.

5

[Increased level of KL-6 in a BJP-λ-type multiple myeloma patient with poor prognosis].

Nakagawa Y, Iizuka H, Nishiyama S, Abe Y, Kusaka S, Sekine R, Suzuki K. Nakagawa Y, et al. Among authors: abe y. Rinsho Ketsueki. 2012 May;53(5):521-5. Rinsho Ketsueki. 2012. PMID: 22728554 Japanese.

6

[Clinical analysis of autologous stem cell transplantation for nine cases of cardiac amyloidosis].

Ogura M, Sekine R, Nishiyama S, Abe Y, Iizuka H, Kusaka S, Nakagawa Y, Suzuki K. Ogura M, et al. Among authors: abe y. Rinsho Ketsueki. 2012 Jul;53(7):710-5. Rinsho Ketsueki. 2012. PMID: 22975774 Japanese.

7

[Primary systemic AL amyloidosis with remarkable calcification in the spleen].

Uchiyama K, Tsukada N, Miyazaki K, Abe Y, Sekine R, Nakagawa Y, Suzuki K. Uchiyama K, et al. Among authors: abe y. Rinsho Ketsueki. 2014 Mar;55(3):334-9. Rinsho Ketsueki. 2014. PMID: 24681937 Japanese.

8

[Impacts of new agents for multiple myeloma on development of secondary myelodysplastic syndrome and acute myeloid leukemia].

Hamano A, Shingaki S, Abe Y, Miyazaki K, Sekine R, Nakagawa Y, Tsukada N, Hattori Y, Suzuki K. Hamano A, et al. Among authors: abe y. Rinsho Ketsueki. 2014 Apr;55(4):428-35. Rinsho Ketsueki. 2014. PMID: 24850453 Japanese.

9

[Effective control of skin reaction by air sandwich technique in a patient with IgE-κ myeloma treated with subcutaneous bortezomib injection].

Honda Y, Inoue J, Shingaki S, Miyazaki K, Abe Y, Sekine E, Iki S, Tsukada N, Suzuki K. Honda Y, et al. Among authors: abe y. Rinsho Ketsueki. 2014 May;55(5):570-2. Rinsho Ketsueki. 2014. PMID: 24881924 Japanese.

10

Phase 1 study in Japan of siltuximab, an anti-IL-6 monoclonal antibody, in relapsed/refractory multiple myeloma.

Suzuki K, Ogura M, Abe Y, Suzuki T, Tobinai K, Ando K, Taniwaki M, Maruyama D, Kojima M, Kuroda J, Achira M, Iizuka K. Suzuki K, et al. Among authors: abe y. Int J Hematol. 2015 Mar;101(3):286-94. doi: 10.1007/s12185-015-1743-y. Epub 2015 Feb 6. Int J Hematol. 2015. PMID: 25655379 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,934 results

Search Page

Filters